CD8A and neoplasm: To examine tumor antigen-specific CD8 T cell responses, we constructed an anti-DEC-205 antibody expressing the melanoma antigen human gp100 (anti-DEC-205-hgp100) and asked whether β-catenin in DCs regulated tumor antigen-specific CD8 T cell responses.